Researchers from Vanderbilt University have discovered a new method of vaccination where tiny gold particles target immune cells.
Instead of using dead or inactive parts of a virus, this method involves tiny gold particles mimicking the virus to deliver proteins to the immune system.
The nanotech vaccine showed that the coated particles were not toxic to human cells and could be the answer for the missing vaccine against Respiratory Syncytial Virus (RSV).
Read more at Vanderbilt University